Porcine FcγRIII isoforms are generated by alternative splicing

Molecular Immunology

Volumn 46, Issue 6, 2009, Pages 1189-1194

  Jie, Hyun Bae ^b   Yim, Daesong ^c   Kim, Yoon B ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c BASTYR UNIVERSITY   (United States)

Author keywords

Alternative splicing; Fc RIIIA; Pig; PMN; Soluble CD16

Indexed keywords

CD16 ANTIGEN; ISOPROTEIN; MONOCLONAL ANTIBODY; FC RECEPTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; MALE; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SWINE; ANIMAL; BLOOD; GENETICS; IMMUNOLOGY; IN VITRO STUDY; MONOCYTE; PROTEIN TERTIARY STRUCTURE;

SUIDAE; SUS;

ALTERNATIVE SPLICING; ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; MALE; MONOCYTES; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IGG; SWINE;

EID: 60949089296     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.11.013     Document Type: Article

References (39)

1. Aebi M., Hornig H., and Weissmann C. 5′ cleavage site in eukaryotic pre-mRNA splicing is determined by the overall 5′ splice region, not by the conserved 5′ GU. Cell 50 (1987) 237-246
2. Astier A., de la Salle H., de la Salle C., Bieber T., Esposito-Farese M.E., Freund M., Cazenave J.P., Fridman W.H., Teillaud J.L., and Hanau D. Human epidermal Langerhans cells secrete a soluble receptor for IgG (Fc gamma RII/CD32) that inhibits the binding of immune complexes to Fc gamma R+ cells. J. Immunol. 152 (1994) 201-212
3. Bouhlal H., Galon J., Kazatchkine M.D., Fridman W.H., Sautes-Fridman C., and Haeffner Cavaillon N. Soluble CD16 inhibits CR3 (CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1. J. Immunol. 166 (2001) 3377-3383
4. Brooks D.G., Qiu W.Q., Luster A.D., and Ravetch J.V. Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J. Exp. Med. 170 (1989) 1369-1385
5. Cook J.P., Henry A.J., McDonnell J.M., Owens R.J., Sutton B.J., and Gould H.J. Identification of contact residues in the IgE binding site of human FcepsilonRIalpha. Biochemistry 36 (1997) 15579-15588
6. Edberg J.C., Redecha P.B., Salmon J.E., and Kimberly R.P. Human Fc gamma RIII (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells. J. Immunol. 143 (1989) 1642-1649
7. Esposito-Farese M.E., Sautes C., de la Salle H., Latour S., Bieber T., de la Salle C., Ohlmann P., Fridman W.H., Cazenave J.P., Teillaud J.L., et al. Membrane and soluble Fc gamma RII/III modulate the antigen-presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens. J. Immunol. 155 (1995) 1725-1736
8. Farber D.L., and Sears D.W. Rat CD16 is defined by a family of class III Fc gamma receptors requiring co-expression of heteroprotein subunits. J. Immunol. 146 (1991) 4352-4361
9. Gachet C., Astier A., de la Salle H., de la Salle C., Fridman W.H., Cazenave J.P., Hanau D., and Teillaud J.L. Release of Fc gamma RIIa2 by activated platelets and inhibition of anti-CD9-mediated platelet aggregation by recombinant Fc gamma RIIa2. Blood 85 (1995) 698-704
10. Galon J., Gauchat J.F., Mazieres N., Spagnoli R., Storkus W., Lotze M., Bonnefoy J.Y., Fridman W.H., and Sautes C. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. J. Immunol. 157 (1996) 1184-1192
11. Galon J., Moldovan I., Galinha A., Provost-Marloie M.A., Kaudewitz H., Roman-Roman S., Fridman W.H., and Sautes C. Identification of the cleavage site involved in production of plasma soluble Fc gamma receptor type III (CD16). Eur. J. Immunol. 28 (1998) 2101-2107
12. Halloran P.J., Sweeney S.E., and Kim Y.B. Biochemical characterization of the porcine Fc gamma RIII alpha homologue G7. Cell. Immunol. 158 (1994) 400-413
13. Halloran P.J., Sweeney S.E., Strohmeier C.M., and Kim Y.B. Molecular cloning and identification of the porcine cytolytic trigger molecule G7 as a Fc gamma RIII alpha (CD16) homologue. J. Immunol. 153 (1994) 2631-2641
14. Hazenbos W.L., Gessner J.E., Hofhuis F.M., Kuipers H., Meyer D., Heijnen I.A., Schmidt R.E., Sandor M., Capel P.J., Daeron M., van de Winkel J.G., and Verbeek J.S. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity 5 (1996) 181-188
15. Hazenbos W.L., Heijnen I.A., Meyer D., Hofhuis F.M., Renardel de Lavalette C.R., Schmidt R.E., Capel P.J., van de Winkel J.G., Gessner J.E., van den Berg T.K., and Verbeek J.S. Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J. Immunol. 161 (1998) 3026-3032
16. Henry A.J., Cook J.P., McDonnell J.M., Mackay G.A., Shi J., Sutton B.J., and Gould H.J. Participation of the N-terminal region of Cepsilon3 in the binding of human IgE to its high-affinity receptor FcepsilonRI. Biochemistry 36 (1997) 15568-15578
17. Huizinga T.W., de Haas M., Kleijer M., Nuijens J.H., Roos D., and von dem Borne A.E. Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J. Clin. Invest. 86 (1990) 416-423
18. Hulett M.D., and Hogarth P.M. Molecular basis of Fc receptor function. Adv. Immunol. 57 (1994) 1-127
19. Hulett M.D., Witort E., Brinkworth R.I., McKenzie I.F., and Hogarth P.M. Identification of the IgG binding site of the human low affinity receptor for IgG Fc gamma RII. Enhancement and ablation of binding by site-directed mutagenesis. J. Biol. Chem. 269 (1994) 15287-15293
20. Hulett M.D., Witort E., Brinkworth R.I., McKenzie I.F., and Hogarth P.M. Multiple regions of human Fc gamma RII (CD32) contribute to the binding of IgG. J. Biol. Chem. 270 (1995) 21188-21194
21. Jackson I.J. A reappraisal of non-consensus mRNA splice sites. Nucleic Acids Res. 19 (1991) 3795-3798
22. Johnson B.D., and Kim Y.B. Characterization of a monoclonal antibody enhancing porcine natural killer cell activity (PNK-E). Cell. Immunol. 125 (1990) 107-119
23. Johnson B.D., Wierda W.G., and Kim Y.B. Further characterization of PNK-E: a monoclonal antibody enhancing porcine natural killer cell activity. Cell. Immunol. 134 (1991) 378-389
24. Kim Y.B., Huh N.D., Koren H.S., and Amos D.B. Natural killing (NK) and antibody-dependent cellular cytotoxicity (ADCC) in specific pathogen-free (SPF) miniature swine and germfree piglets. I. Comparison of NK and ADCC. J. Immunol. 125 (1980) 755-762
25. Nimmerjahn F., and Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8 (2008) 34-47
26. Patry C., Sibille Y., Lehuen A., and Monteiro R.C. Identification of Fc alpha receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J. Immunol. 156 (1996) 4442-4448
27. Porges A.J., Redecha P.B., Doebele R., Pan L.C., Salmon J.E., and Kimberly R.P. Novel Fc gamma receptor I family gene products in human mononuclear cells. J. Clin. Invest. 90 (1992) 2102-2109
28. Qiu W.Q., de Bruin D., Brownstein B.H., Pearse R., and Ravetch J.V. Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. Science 248 (1990) 732-735
29. Ravetch J.V., and Kinet J.P. Fc receptors. Annu. Rev. Immunol. 9 (1991) 457-492
30. Ravetch J.V., and Perussia B. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J. Exp. Med. 170 (1989) 481-497
31. Sarmay G., Rozsnyay Z., Koncz G., Danilkovich A., and Gergely J. The alternative splicing of human Fc gamma RII mRNA is regulated by activation of B cells with mIgM cross-linking, interleukin-4, or phorbolester. Eur. J. Immunol. 25 (1995) 262-268
32. Sylvestre D.L., and Ravetch J.V. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265 (1994) 1095-1098
33. Sylvestre D.L., and Ravetch J.V. A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity 5 (1996) 387-390
34. Tepler I., Shimizu A., and Leder P. The gene for the rat mast cell high affinity IgE receptor alpha chain. Structure and alternative mRNA splicing patterns. J. Biol. Chem. 264 (1989) 5912-5915
35. van de Winkel J.G., Ernst L.K., Anderson C.L., and Chiu I.M. Gene organization of the human high affinity receptor for IgG, Fc gamma RI (CD64). Characterization and evidence for a second gene. J. Biol. Chem. 266 (1991) 13449-13455
36. Wierda W.G., Johnson B.D., Dato M.E., and Kim Y.B. Induction of porcine granulocyte-mediated tumor cytotoxicity by two distinct monoclonal antibodies against lytic trigger molecules (PNK-E/G7). J. Immunol. 151 (1993) 7117-7127
37. Wierda W.G., Johnson B.D., Dato M.E., and Kim Y.B. Two distinct porcine natural killer lytic trigger molecules as PNK-E/G7 molecular complex. Cell. Immunol. 146 (1993) 270-283
38. Wu Q., and Krainer A.R. AT-AC pre-mRNA splicing mechanisms and conservation of minor introns in voltage-gated ion channel genes. Mol. Cell. Biol. 19 (1999) 3225-3236
39. Zhang Y., Boesen C.C., Radaev S., Brooks A.G., Fridman W.H., Sautes-Fridman C., and Sun P.D. Crystal structure of the extracellular domain of a human Fc gamma RIII. Immunity 13 (2000) 387-395